ENTERA BIO LTD (ENTX:NASDAQ)

$1.22 0.03 (2.521%)

watchlist-icon
search-icon
Profile Icon

Most Recent Average Sentiment Analysis Score (0 to 100): 73

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]
Visualize Sentiment Trendline

Analysed ENTERA BIO LTD (ENTX:NASDAQ) News Sources

Matricelf Ltd. (TASE: MTLF) Appoints Ron Mayron as Chairman of the Board

27-02-2026

yahoo.com

Entera Bio Submits Streamlined Phase 3 Protocol to Initiate Registrational Program for EB613 in Postmenopausal Women with Osteoporosis

04-03-2026

yahoo.com

Entera Bio Announces Full Year 2025 Financial Results and Provides Business Updates

27-03-2026

yahoo.com

Entera Bio Announces Pricing of $10.0 Million Direct Investment by BVF Partners with Potential for up to $24.5 Million in Total Proceeds

02-04-2026

yahoo.com

Entera Bio to Host Key Opinion Leader Webinar Highlighting the Osteoporosis Treatment Landscape and the Opportunity for EB613

14-04-2026

yahoo.com

BriefCast Publishes Transcript: Entera Bio's Osteoporosis KOL Roundtable on EB613 - Oral Anabolic Tablet Opportunity

20-04-2026

yahoo.com

Entera Bio Touts EB613 Oral Anabolic Tablet as Osteoporosis Care Gap Persists, Phase III Near

24-04-2026

marketbeat.com

Entera Bio (ENTX) Upgraded to Buy: Here's What You Should Know

29-04-2026

yahoo.com

Entera Announces First Quarter 2026 Financial Results and Updates Across its Oral Peptide Programs

08-05-2026

yahoo.com

Entera’s EB613, First-in-Class Oral PTH(1-34) Anabolic for Osteoporosis - Single Tablet Data Selected for Late Breaking Oral Presentation at ENDO 2026 Annual Meeting; Additional Oral Peptide Pipeline Data Accepted for Presentation

28-05-2026

yahoo.com

ENTERA BIO LTD (ENTX:NASDAQ) Sentiment Trend

0 25 50 75 100 55 56 78 75 69 81 73 91 75 73 27-02-2026 04-03-2026 27-03-2026 02-04-2026 14-04-2026 20-04-2026 24-04-2026 29-04-2026 08-05-2026 28-05-2026 #1 #2 #3 #4 #5 #6 #7 #8 #9 #10 Negative < 35 Neutral 35–65 Positive > 65 View FAQ

ENTERA BIO LTD (ENTX:NASDAQ) FAQs

toggle

What is the current price of ENTERA BIO LTD (ENTX:NASDAQ)?

The current price of ENTERA BIO LTD (ENTX:NASDAQ) is $1.22.


toggle

ENTERA BIO LTD (ENTX:NASDAQ) absolute price change since previous trading day?

The absolute price change of ENTERA BIO LTD (ENTX:NASDAQ) since the previous trading day is $0.03.


toggle

ENTERA BIO LTD (ENTX:NASDAQ) percentage price change since previous trading day?

The percentage price change of ENTERA BIO LTD (ENTX:NASDAQ) since the previous trading day is 2.521%.


toggle

What is the most recent average sentiment score for ENTERA BIO LTD (ENTX:NASDAQ)?

The most recent average sentiment score for ENTERA BIO LTD (ENTX:NASDAQ) is 73 out of 100.


toggle

What is the most recent average sentiment for ENTERA BIO LTD (ENTX:NASDAQ)?

The most recent sentiment for ENTERA BIO LTD (ENTX:NASDAQ) is .


SEC-8K** Filing Available For ENTERA BIO LTD (ENTX:NASDAQ)

** material developments that could impact a company's financial condition or stock price.

Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.